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Background: Insulin and insulin-like growth factors (IGFs) act on tetrameric tyrosine kinase receptors controlling
essential functions including growth, metabolism, reproduction and longevity. The insulin receptor (IR) binds insulin
and IGFs with different affinities triggering different cell responses.
Results: We showed that IGF-II induces cell proliferation and gene transcription when IR-B is over-expressed. We
combined biotinylated ligands with streptavidin conjugated quantum dots and visible fluorescent proteins to
visualize the binding of IGF-II and insulin to IR-B and their ensuing internalization. By confocal microscopy and flow
cytometry in living cells, we studied the internalization kinetic through the IR-B of both IGF-II, known to elicit
proliferative responses, and insulin, a regulator of metabolism.
Conclusions: IGF-II promotes a faster internalization of IR-B than insulin. We propose that IGF-II differentially
activates mitogenic responses through endosomes, while insulin-activated IR-B remains at the plasma membrane.
This fact could facilitate the interaction with key effector molecules involved in metabolism regulation.
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Background: The insulin receptor (IR) responds to in-
sulin and IGF-II regulating glucose metabolism, cellular
growth and differentiation. Results: Using quantum dot-
conjugated IGF-II and insulin we analyzed IR-B endo-
cytosis in correlation with mitogenicity of each ligand.
Conclusions: IGF-II promotes a fast IR internalization
favoring mitogenic signaling whereas insulin-activated
IR would endures signaling from the membrane. Signifi-
cance: Ligand-specific redistribution of activated IR en-
sures signal specificity.
Background
Insulin and insulin-like growth factors (IGFs) are polypep-
tide hormones common to all metazoans [1]. They con-
trol essential functions including growth, metabolism,* Correspondence: federico@fbmc.fcen.uba.ar
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reproduction in any medium, provided the orreproduction and longevity which are triggered by activa-
tion of tetrameric tyrosine kinase receptors [2-9]. During
vertebrate and invertebrate embryonic development, insu-
lin and IGFs act as mitogenic growth factors. In postnatal
vertebrates, insulin acts as a specialized metabolic hor-
mone regulating glucose homeostasis, whereas IGFs retain
their mitogenic functions. Invertebrates possess several
insulin-like growth factors genes but only one receptor,
DAF-2 [2,10-12]. In contrast, vertebrates express 3 hor-
mone peptides (insulin, IGF-I and IGF-II) and 3 distinct
DAF-2 homologous genes: the insulin receptor (Ir)
[13,14], the IGF-I receptor (Igf1r) [15] and the orphan re-
ceptor IR related receptor (Irr) [16,17]. Moreover, the
mammalian Ir gene acquired an alternative exon and the
ability to regulate its inclusion in a developmental and
tissue specific manner. Exon 11 skipping leads to the an-
cestral IR-A [14], whereas its inclusion leads to the novel
IR-B [13]. IR splicing appears altered in aging and in dif-
ferent pathologic states such as type 2 diabetes mellitus
and myotonic dystrophy and cancer [18-20].
IGF-I and IGF-II are produced primarily by the liver.
IGF-I biosynthesis tightly correlates with the circulating
levels of growth hormone, such that Igf1 gene expressionl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[21]. Although the biological functions of IGF-I and
IGF-II are similar in mammals, in humans circulating
IGF-II exceeds IGF-I levels throughout post-natal life.
IGFs bind to the IGF-IR, expressed in almost all cell
types, promoting cellular growth and proliferation and
inhibiting apoptosis. These growth factors stimulate
DNA synthesis and regulate development and differenti-
ation in a large variety of cell types, thus playing a key
role in the maximum size acquired by an organism. For
example, the extreme variability in the size of dogs (the
greatest of any vertebrate) is due to polymorphisms
present in the Igf1 gene [22]. It was also shown that a
population carrying mutations in the growth hormone
receptor gene has lower expression levels of the growth
hormone receptor and IGF-I, while exhibiting a very low
incidence of cancer and absence of diabetes [23].
The IR and IGF-IR share more than 50% sequence
identity and up to 85% in their kinase domain [15,24].
IGF-IR and IR have a conserved modular protein struc-
ture [15,25], being able to bind both insulin and IGFs.
However, since IGF-IR shows higher affinity for IGF-I
and IR for insulin, it is well accepted that insulin meta-
bolic effects are mediated by IR whereas growth stimula-
tion is due to IGF-IR signaling [1].
Almost all mammalian cells express either IR or IGF-
IR but at different levels [26-28]. When the two recep-
tors are co-expressed, pro-receptors heterodimerize in
the Golgi leading to hybrid receptors IR/IGF-IR [29-33],
which presumably would be responsible for the cellular
responses to IGF-I, IGF-II and insulin. It has been pro-
posed that hybrid receptors are involved in insulin resist-
ance in type 2 diabetes by lowering the number of
hormone binding sites. In addition, a large fraction of
hybrid receptors increases the binding sites for IGFs, a
situation associated with a number of different types of
cancer [27,34].
The above body of information reinforces the import-
ance of understanding the differences between the sig-
naling triggered by different ligands through the axes IR/
IGF-IR. The affinities of insulin, IGF-I and IGF-II for IR-
A and IR-B as well as for IGF-IR and hybrid receptors
have been studied by different groups with contradictory
results [27,33,35,36].
In the present study we analyzed the dynamics of sig-
naling and endocytosis of IR-B after stimulation with
insulin and IGF-II. We hypothesized that insulin and
IGF-II would exhibit different endocytosis dynamics and
that these differences would give new insights on the di-
vergence of signaling pathways that could be triggered
from the same receptor upon binding of different li-
gands. We combined techniques that allowed us to study
and visualize individual cells by microscopy and flow cy-
tometry. We tracked insulin and IGF-II endocytosis inliving cells by using biotinylated ligands conjugated with
streptavidin fluorescent nanoparticles (quantum dots or
QD). Insulin and IGF-II promoted different endocytosis
dynamic of IR-B, suggesting a mechanism for the diver-
gent signaling pathways that can be trigger from a same
receptor upon binding different ligands.
Results
IGF-II induces IR-B phosphorylation
We evaluated the effect of IGF-II on IR-B activation by
confocal microscopy and Western blot. HeLa cells were
transfected with pcDNA3-IR-B, serum starved and stim-
ulated with 100 nM human IGF-II or recombinant hu-
man insulin (rhIns) for 5 min at 37°C. Lysates were
assayed by Western blot, showing that IR-B responds to
IGF-II and to rhIns (Figure 1A). Immunoblotting was
carried on using a general antibody against phosphory-
lated tyrosine (PY20). The activation signal upon ligand
binding was only present in cells over-expressing IR-B
showing a band of the correct size of the β-subunit of
the insulin receptor (~95 kDa). Figure 1B shows a repre-
sentative Western blot where the cells were transfected
with the empty pcDNA3 (EV) showing that the levels of
endogenous IR were almost not detected, neither its
phosphorylation.
We evaluated HeLa endogenous levels of IR-A and IR-
B by reverse transcription and PCR (RT-PCR) observing
a 24% ± 6% exon 11 inclusion (Additional file 1: Figure
S1A). This is consistent with HeLa’s tumor origin and
the reports showing a switch in the ratio of IR-A/IR-B in
cancer cells [23,33,37]. Endogenous levels of IR and
IGF-IR mRNA were measured by RT-PCR and normal-
ized to GADPH mRNA showing a mRNA relative abun-
dance of 1.1% ± 0.4% for IR and 8.1% ± 1.0% for IGF-IR
(Additional file 1: Figure S1B). Correct identity of over-
expressed IR-B was analyzed by sequencing and PCR
(Additional file 1: Figure S1C).
In order to discriminate the contribution of the trans-
fected IR-B from the endogenous receptors we measured
IR activation in single cells expressing IR-B fused with the
super cyan fluorescent protein (SCFP) (IR-B-SCFP) by
immunofluorescence using a specific antibody against
phosphorylated IR-β subunit (Tyrosine 1361). We
detected activation of IR-B at the plasma membrane after
stimulating with 100 nM IGF-II or rhIns (Figure 1C).
Non-transfected cells did not show any activation signal
(pointed with arrows in Figure 1C). Signal colocalization
between IR-B-SCFP and phosphorylated IR-β confirms
that receptor activation triggered by ligand binding is orig-
inated from the over-expressed IR-B (Figure 1D).
We next estimated IR transfection efficiency ranging
between 30 and 60% by microscopy using DIC (total
cells) and fluorescence (transfected) images (n = 219 cells
for IR fused to visible fluorescent proteins (VFP) and
Figure 1 IR activation by IGF-II and IGF-II-biotin. A. HeLa cells over-expressing IR-B were starved for 16 hours and stimulated for 5 min with
100 nM rhIns, BAC-Ins, IGF-II or IGF-II-biot at 37°C. Lysates were analyzed by Western blot with anti-phosphorylated-Tyrosine (p-Tyr) and anti-IR-β
subunit antibodies; and anti-phosphorylated-ERK 1/2 (p-ERK) and anti-ERK 1/2 antibodies. B. HeLa cells were transfected with pcDNA3-IR-B or EV
stimulated or not with insulin for 5 min (bands were cut from the same gel). C. HeLa cells expressing IR-B-SCFP stimulated with 100 nM IGF-II,
IGF-II-biot or rhIns for 5 min at 37°C, fixed in cold methanol and analyzed by immunofluorescence with anti-phosphorylated-IR-β subunit
(Tyrosine 1361) antibody and a secondary antibody conjugated with Alexa fluor 555. Imaging was performed by confocal microscopy (Olympus
Fluoview FV1000). Scale bars: 10 μm. Arrows indicate that non transfected cells do not show activation signal upon ligand stimulation. Arrows
indicate non transfected cells. D. Colocalization analysis performed with Image J. Product of the differences from the mean (PDM) plots and
Manders coefficients for each channel (MpIR-555 and MSCFP) are shown for stimulation with IGF-II and rhIns.
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pendent experiments) (Additional file 2: Figure S2).
IGF-II induces cell proliferation through IR-B
It is known that IGF-II is a mitogenic ligand for the IR
[37,38]. In order to evaluate insulin and IGF-II-induced
proliferation though IR-B, cells transfected with pcDNA3-
IR-B or the EV were starved with 1% FBS overnight and
then treated with vehicle or 0.1 nM, 1.0 nM or 10.0 nM
IGF-II or rhIns for 2 days after which cell proliferation
was measured by a non-radioactive assay. Data was nor-
malized to those obtained with vehicle treated cells. Cells
transfected with EV did not show any dependence onFigure 2 Proliferative response of IGF-II and rhIns through IR-B. A. He
by Western blot detecting the expression of IR and ERK 1/2 (loading contro
stimulated with 0.1 nM, 1.0 nM and 10.0 nM IGF-II or rhIns for 2 days. The r
Asterisks indicate significant differences between IR and EV (p < 0.05).ligand concentration (Figure 2). This result suggests negli-
gible contribution of the endogenous levels of IR and IGF-
IR in this proliferation assay. In contrast, both insulin and
IGF-II induced a proliferative response in a dose depen-
dent manner in IR-B over-expressing cells (Figure 2)
(insulin: 1.3 ± 0.1 for 0.1 nM, 1.9 ± 0.2 for 1.0 nM and 2.1 ±
0.1 for 10.0 nM; IGF-II: 1.4 ± 0.2 for 0.1 nM, 2.1 ± 0.3 for
1.0 nM and 2.4 ± 0.3 for 10.0 nM). In both cases these re-
sults were statistical different than those obtained in cells
transfected with EV.
These data suggest that IGF-II induces cell prolife-
ration via IR-B. Although a higher proliferative res-
ponse was observed for IGF-II as compare to insulin,La cells transiently transfected with pcDNA3-IR-B or EV were assayed
l). B. MTS assay in cells transiently transfected with pcDNA3-IR-B or EV
esults are shown as the mean ± s.e.m (n = 3 independent experiments).
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cally significant.IGF-II induces AP-1 dependent gene transcription through
IR-B
We measured AP-1 dependent gene transcription using
a Luciferase reporter assay in cells over-expressing IR-B
(Figure 3A). For this purpose, first we evaluated the ef-
fects of IGF-II and insulin on endogenous receptors.
HeLa cells are derived from an epithelial tumor and are
well known to respond to the epidermal growth factor
(EGF), that can be suitably used as a positive control
(Figure 3B). No effect on gene transcription was ob-
served upon stimulation with IGF-II and/or rhIns. These
results confirm an insignificant contribution of endogen-
ous IR and IGF-IR. Next, we evaluated, in IR-B express-
ing HeLa cells, the effects of EGF in combination with
IGF-II or rhIns on AP-1 induction. IR-B over-expressing
cells showed a significant response to rhIns and IGF-II,
without affecting EGF induction (Figure 3C, right). Co-
stimulation with EGF and rhIns showed an additive ef-
fect on AP-1 induction, suggesting that both ligands
activate AP-1 through different pathways. This response
was statistically different from rhIns alone (p ≤ 0.005). In
contrast, cells treated with rhIns + IGF-II did not exhibit
a combined response, indicating that these ligands in-
duced AP-1 through the same receptor (Figure 3C, left).Figure 3 AP-1 mediated gene transcription induced by IGF-II via IR-B.
assayed by Western blot detecting the expression of IR and β-actin (loadin
EV. After 24 hours, serum was depleted for 1 day and cells were stimulated
EGF + 100nM rhIns or 100 nM IGF-II + 100 nM rhIns. Luciferase induction w
The results are shown as the mean ± s.e.m (n = 4 independent experiments
II and IGF-II + rhIns and n = 7 for rhIns). Asterisks indicate significant differen
cotransfected with pAP1-Luc and pcDNA3-IR-B or EV were stimulated with
100 nM IGF-II + 100 nM rhIns for 16 hours and luciferase activity was measu
experiments for EGF, rhIns and EGF + rhIns; n = 3 independent experiments
(p < 0.01) between cells over-expressing IR-B with cells transfected with EV.
EGF + rhIns stimulation is significantly different form rhIns alone either in ce
(p = 0.005).Imaging of ligand-receptor complexes endocytosis
In order to visualize the ligand receptor endocytosis
using QD, commercially available biotinylated ligands,
biotin amido caproyl insulin (BAC-Ins) and IGF-II-biot,
were used [39]. We confirmed by Western blot and im-
munofluorescence that BAC-Ins and IGF-II-biot were
capable of activating IR-B (Figure 1A-B). To visualize
the receptor we used IR-B fused with different VFPs.
These proteins localized properly at the plasma membrane
and were positively stained with two different antibodies
against regions of the N-terminus of the α-subunit of IR
(N20 and H78) (Additional file 3: Figure S3).
The two step labeling strategy is schematically summa-
rized in Figure 4A. Briefly, live HeLa cells expressing IR-
B were treated at 15°C or room temperature with
biotinylated ligands for 15 min. After washing the free
ligand, cells were incubated 10 min with streptavidin
conjugated QD655 (QD with emission peak at 655 nm),
washed to remove unbound QD655 and incubated at
37°C for different time periods.
To evaluate the optimal QD655 concentration, HeLa
cells expressing IR-B-GFP were incubated with 50 nM
BAC-Ins followed by variable concentrations of QD655
(Figure 4B). Cells were fixed with PFA and imaged by con-
focal microscopy. Control cells without previous incuba-
tion with BAC-Ins did not show any signal (Figure 4B,
first column). We calculated the ratio between QD655
and GFP signals (see Methods) observing a dose responseA. HeLa cells transiently transfected with pcDNA3-IR-B or the EV
g control). B. Luciferase activity on cells transfected with pAP1-Luc and
for 16 hours with: 1.6 nM EGF, 100 nM rhIns, 100 nM IGF-II, 1.6 nM
as calculated as the ratio between stimulated and non-stimulated cells.
for EGF, rhIns and EGF + rhIns; n = 3 independent experiments for IGF-
ces (p = 0.005) with non transfected cells (control). C. Cells
: 1.6 nM EGF, 100 nM rhIns, 100 nM IGF-II, 1.6 nM EGF + 100nM rhIns or
red. The results are shown as the mean ± s.e.m. (n = 4 independent
for IGF-II and IGF-II + rhIns). Asterisks indicate significant differences
In B and C panels the symbol # indicates that AP-1-Luc response after
lls over-expressing IR-B (p = 0.007) or in cells transfected with EV
Figure 4 Imaging of biotinylated ligands binding and internalization by QDs. A. Labeling strategy. B. QD655 concentration curve: HeLa
cells expressing IR-B-GFP were labeled with 50 nM BAC-Ins for 15 min and different concentration of QD655 (0.5 nM to 4.0 nM) for 10 min at
15°C. Quantification of the ratio between QD655 and GFP signal (GFP/QD655). Asterisks indicate significant differences: * p < 0.0001 and ** p =
0.01 (n = 6–10 cells). C. HeLa cells expressing IR-B-GFP were labeled in vivo with 50 nM BAC-Ins and 1 nM QD655 at 15°C and further either
directly fixed in 3.7% PFA or treated with acid solution (0.5 M NaCl, 0.1 M Na-glycine pH 3.0) for 5 min and washed before fixation. The two
bottom panels show similar experiments but the cells were incubated at 37°C for 150 min before acid treatment and/or fixation. In all the cases
imaging was performed by confocal microscopy (Zeiss LSM 510 Meta). Scale bars: 10 μm. D. HeLa cells expressing IR-B were labeled with 50 nM
BAC-Ins and 1 nM QD655 at room temperature. Samples were incubated or not at 37°C and then fixed in 3.7% PFA. Immunofluorescence was
performed with antibodies against early endosomes (EEA1) or CD63 (Lamp 1). Secondary antibodies were conjugated with Alexa fluor 555.
Imaging was performed by confocal microscopy (Olympus Fluoview FV 1000). Scale bars: 10 μm.
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From these results a non saturating concentration of 1
nM QD655 was chosen for further work
The internalization of IR-B-GFP in living cells was ana-
lyzed by sequentially labeling HeLa cells with 50 nMBAC-Ins and 1 nM QD655. Cells were directly fixed in
3.7% PFA or incubated at 37°C for 150 min before fixation
(Figure 4C). At the beginning GFP and QD655 signals co-
localized at the plasma membrane. By contrast, after 150
min at 37°C the majority of QD655 signal was located in
Giudice et al. Cell Communication and Signaling 2013, 11:18 Page 6 of 15
http://www.biosignaling.com/content/11/1/18the cytoplasm, in the perinuclear region. In order to con-
firm the internalization, cells were treated with an acid so-
lution (0.5 M NaCl, 0.1 M Na-glycine pH 3.0) for 5 min
and washed before fixation. Acid would induce the dis-
sociation between ligand and receptor at the cell surface
[40]. These experiments showed that, while in samples
that were not incubated at 37°C the acid treatment re-
moved completely QD655 signal (without affecting IR-B
-VFP signal), cells incubated at 37°C maintained the inter-
nalized QD655 signal. To evaluate whether the size or the
nature of the nanoparticles could be affecting the observed
results, similar experiments were performed but treating
cells with 50 nM BAC-Ins and sequentially with 1 nM
fluorescent streptavidin (SA-atto 550) (Additional file 4:
Figure S4A). Additionally, cells were directly incubatedFigure 5 IGF-II binding and internalization via IR by confocal microsc
nM IGF-II-biot and 2 nM QD655 at room temperature and fixed in 3.7% PFA
and treated with acid (0.5 M NaCl, 0.1 M Na-glycine pH 3) for 5 min before
Fluoview FV 1000). Scale bars: 10 μm. B. HeLa cells expressing IR-B-GFP we
for 1 hour at 37°C, then with 0.1 mM Na-glycine pH 3, NaCl 0.5 M for 5 min
microscope (Olympus Fluoview FV 1000) by acquisition of 64 z-slices with
Volume Imaging Huygens Professional Version 3.6, applying the Quick max
are shown. C. Maximum intensity projection. D. Surface renderer. Different
μm) that is shown in the right lower corner of the third panel. Scale bars: 5
IGF-II (ratio between QDinterior and QDtotal). The results are shown as the m
between ligands (p≤ 0.02). In A and B white arrows indicate internalized Qwith 50 nM fluorescently labeled insulin (FITC-insulin)
(Additional file 4: Figure S4B). Although brightness and
photostability were compromised, both strategies showed
a similar labeling pattern as compare to QD655 either at
the onset or after internalization.
In order to trace the insulin-IR endocytic pathway we
performed immunofluorescence experiments using early
endosomes (EEA1) and lysosome markers (Lamp 1). After
20 min, co-localization between QD655 and early endo-
somes was observed while at 45 min, the QD655 signal was
mainly located at perinuclear lysosomes (Figure 4D).
Visualization of IGF-II bound to IR-B and its endocytosis
We have previously shown that IGF-II and IGF-II-biot in-
duce IR-B activation followed by ERK 1/2 phosphorylation,opy. A. HeLa cells expressing IR-B-SYFP were labeled in vivo with 50
. Lower panel shows cells incubated at 37°C for 150 min after labeling
fixation. Imaging was performed by confocal microscopy (Olympus
re labeled in vivo with 50 nM IGF-II-biot and 2 nM QD655, incubated
and fixed in 3.7% PFA. Images were taken with a confocal
16 μm step size. Deconvolution was performed with Huygens Scientific
imum likelihood estimation algorithm. Tridimensional reconstructions
views are shown. Lower panels show views of 14 z-slices section (2.24
μm. E. Quantification of the degree of internalization of insulin and
ean ± s.e.m (n = 19–29 cells). Asterisks indicate significant differences
D655 and orange arrows label non transfected cells.
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IGF-II induced endocytosis of IR-B in individual cells, HeLa
cells expressing IR-B-SYFP were incubated with 50 nM
IGF-II-biot for 15 min and labeled with 1 nM QD655 for
10 min at room temperature. Confocal microscopy revealed
that IGF-II bound specifically to IR-B-SYFP: no signal was
detected in non-transfected cells (Figure 5A, arrows). When
cells were incubated at 37°C for 150 min after labeling,
internalization of IGF-II-QD655 was detected only in trans-
fected cells. Internalization was confirmed by exposure of
the cells to an acidic solution (5 min, 0.5 M NaCl, 0.1 M
Na-glycine pH 3.0) before fixation. The data demonstrates
that ligand-QD complexes were exclusively localized at the
plasma membrane and internalized only after subsequent
incubation at 37°C. QD655 signal was only detected inside
the cell (Figure 5A, second row panels). The intracellular
localization of IGF-II-QD655 complexes was assessed in
more detail by optical sectioning. We acquired 64 confocal
z-slices with a 16 μm step size of cells expressing IR-B-GFP
labeled as described above, incubated for 150 min at 37°C
and treated for 5 min with acid before fixation. Deconvo-
lution of the images by a Quick Maximum Likelihood
Estimation (QMLE) algorithm and tridimensional recon-
struction of the cells evidenced the presence of IGF-II-
QD655 in the perinuclear region partially co-localizing with
IR-B-GFP (Figure 5B-D and Additional file 5: Movie S1).
Kinetics of IGF-II and insulin internalization by microscopy
The kinetics of ligand internalization of IGF-II and insu-
lin was quantified by labeling HeLa cells expressing
IR-B-SYFP with 50 nM IGF-II or BAC-Ins and 1 nM
QD655 and further incubating at 37°C for 10, 20 or 150
min. QD655 signal inside the cells increased over time,
indicating that endocytosis had taken place (Figure 5A).
The extent of endocytosis was quantified after segmenta-
tion of each cell into membrane and interior, calculating
the ratio between the signal from the cytosol (QDinterior)
over the total (QDtotal = QDinterior + QDmembrane) (ratio:
QDinterior/QDtotal) using image processing tools on indi-
vidual cells at different time points (See Methods)
(Figure 5E). Only cells with similar IR-B-SYFP expres-
sion levels (estimated by the VFP intensity signal) were
considered since high expression levels of IR affect in-
ternalization rates (data not shown). The data indicate
that IGF-II internalized faster than insulin through IR-B.
After short incubation at 37°C the fraction of internal-
ized IGF-II-biot-QD655 (10 min: 0.60 ± 0.03; 20 min:
0.72 ± 0.03; n = 20 cells) was significantly higher than
that of BAC-Ins-QD655 (10 min: 0.38 ± 0.03 and 20
min: 0.41 ± 0.03; n = 10–20 cells) in cells over-expressing
IR-B (p < 0.00001). Differences between both ligands
were also significant at the onset of the experiment.
While insulin internalization at room temperature is negli-
gible (0.06 ± 0.01), IGF-II is significantly endocytosed(0.17 ± 0.03) (p = 0.002; n = 28–29 cells). Data were fitted
to a sigmoideal curve (logistic) and the first derivative in
each time point was calculated finding the maximal k
(kmax). This analysis showed a higher kmax for IGF-II
((0.034 ± 0.002) min-1) than for insulin ((0.021 ± 0.001)
min-1). At longer incubation times (150 min) both ligands
are equally and almost completely internalized (IGF-II:
0.96 ± 0.01 and Insulin: 0.95 ± 0.01; n = 19–23 cells) (see
Table 1).
IGF-II and insulin rate of internalization by flow cytometry
The results obtained by microscopy were confirmed
measuring IGF-II internalization by flow cytometry de-
tecting QD655 and SYFP signal. First, the specificity of
QD655 binding to biotinylated ligands was evaluated in
cells expressing IR-B or IR-B-SYFP and treated with
QD655 with or without previous incubation with BAC-
Ins, showing that the number of events with high QD655
signal was significantly higher when BAC-Ins was added
(Additional file 6: Figure S5). On the other hand, the
population of events showing high QD655 intensity
shifted to the right if the cells expressed IR-B fused to a
fluorescent protein confirming that only transfected cells
are binding BAC-Ins-QD655 (Additional file 6: Figure S5).
We defined four regions according to fluorescence inten-
sity and quantified the events inside region II (high SYFP
and QD655 signals) in cells expressing IR-B-SYFP treated
with QD655 with or without BAC-Ins. We normalized
these data to control cells without transfection (fold with
respect to the control: 1.1 ± 0.1 for cells treated only with
QD655 and 5.4 ± 0.3 for cells incubated with BAC-Ins
and QD655; n = 3 independent experiments, p < 0.0005)
confirming specific labeling (Additional file 6: Figure S5F).
After confirming that flow cytometry allows us to
detect specific binding of biotinylated ligands to IR-B
in living and individual cells, we tested whether acid
treatment could remove receptor-bound ligands at the
plasma membrane. Cells expressing IR-B-SYFP were la-
beled with IGF-II-biot and QD655 and incubated with
acid for 2 min. Living cells were analyzed by flow cytom-
etry quantifying SYFP and QD655 signals. We estimated
the ratio between the number of events showing high
QD655 and SYFP signals (quadrant II) over the total
events with high SYFP signal (quadrants II + IV; i.e.,
transfected cells) before and after acid treatment. The
analysis showed that acid treatment removes the IGF-II
-biot-QD655 bound to IR at the plasma membrane
(Additional file 6: Figure S5G). Similar experiments were
performed by incubating labeled cells for 20, 40 and 90
minutes at 37°C prior to acid treatment. The data were
first analyzed by selecting the events with high SYFP sig-
nal (transfected cells) and generating QD655 histograms.
The histograms showed that longer incubation at 37°C
increased the QD655 geometric mean values, validating
Table 1 Internalization of IGF-II and insulin through IR-B by microscopy
Time at 37°C 0 min 10 min 20 min 150 min
Ligand Insulin IGF-II Insulin IGF-II Insulin IGF-II Insulin IGF-II
Average 0.06 0.17 0.38 0.60 0.41 0.72 0.95 0.96
s.e.m 0.01 0.03 0.03 0.03 0.03 0.03 0.01 0.01
n 28 29 10 20 20 20 23 19
p (insulin versus IGF-II) 2E-03 9E-06 7E-09 9E-01
Quantification of the degree of internalization of IGF-II and insulin in HeLa cells expressing IR-B-SYFP labeled in vivo with 50 nM BAC-Ins and 1 nM QD655 at
room temperature.
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biot-QD655 (Figure 6A). While the geometric mean did
not change in acid untreated cells, it did increase over
the time in acid treated cells. Analysis of the histograms
for IGF-II and insulin internalization over the time re-
vealed a shift of the geometric mean of the QD655 sig-
nal (Figure 6B-C). We quantified the high QD655 signal
events using a marker M1 on each histogram including
approximately 4% of the events at the time defined as
zero (0 min). For each incubation point we determined
the percentage of events inside the region M1 and nor-
malized it to the value obtained for the time defined as
zero (Marker/0 min). According to the M1 marker, a
greater fraction of IR expressing cells internalized IGF-
II-biot-QD655 than BAC-Ins-QD655. These differences
were statistical significant (p = 0.01) after short incuba-
tion times (20 min), confirming the faster interna-
lization dynamics induced by IGF-II than by insulin
(Figure 6D; insulin: 1.7 ± 0.2 and IGF-II: 2.6 ± 0.2; n = 4
independent experiments). We fitted the data to a
sigmoideal curve (logistic) and calculated the first deriv-
atives. The analysis showed that the kmax for IGF-II was
higher ((0.08 ± 0.02) min-1) than the kmax for insulin
((0.06 ± 0.01) min-1). In contrast, data from samples
treated without acid did not show an increase over the
time or a logistic fitting (R2 = 0.57).
Discussion
We showed that IGF-II is a potent IR-B ligand inducing
cell proliferation and AP-1 mediated gene transcription.
Luciferase reporter assays confirmed that IGF-II could
signal specifically through transfected IR since over-
expression of IR-B turns HeLa cells responsive to rhIns
and IGF-II, without affecting the induction promoted by
EGF. Furthermore, while co-stimulation with EGF and
rhIns triggered an additive AP-1 induction, rhIns + IGF-
II did not exhibit a combined response. These results in-
dicate that insulin and IGF-II induce AP-1 through the
same IR/IGF-IR axis when IR is over-expressed, in con-
trast to EGF that signals independently.
The combination of IR-B fused to VFPs with biotinylated
ligands as well as streptavidin conjugated QDs allow to
visualize and quantitatively study IGF-II binding to theIR-B and its ensuing endocytosis. This approach permits to
study endocytosis by tracking the ligand-receptor complex
discriminating the internalized receptors from the cyto-
plasmatic pool. To label the ligand-receptor complexes ex-
clusively at the cell surface we used a combination of
biotinylated ligands and streptavidin conjugated QDs.
Although this could also be reached using fluorescent
streptavidin instead of QDs or fluorescently modified li-
gands, QDs provide powerful advantages for imaging: (a)
high and uniform brilliance, allowing robust quantification
of binding and transport processes, (b) photostability
which is crucial for long term experiments, (c) broad exci-
tation spectrum, allowing the co-imaging with VFPs with-
out bleed-through risk, (d) narrow emission band in the
red part of the spectra well separated from the fluorescence
of the VFPs and (e) proper biochemical stability and
specificity and low background [40]. Specificity of QD in-
ternalization was corroborated since in the absence of bio-
tinylated ligands no QD signal was detected. We showed
that internalization process using biotinylarted ligands +
QDs occurs similarly than when using fluorescent insulin
or biotinylated ligands + fluorescent streptavidin. The in-
ternalization of the complexes through endocytosis was
also confirmed by co-localization with endocytosis markers
during the process.
Additionally, the effect of biotinylation over ligand ac-
tivity was controlled, biotinylated-IGF-II triggered IR-B
signaling activation to a similar degree than human IGF-
II measured as IR auto-phosphorylation and ERK 1/2
activation.
The endocytosis of IGF-II by IR-B exhibited to pro-
ceed with a faster kinetics than that of insulin measured
both by confocal microscopy and flow cytometry. These
techniques showed to be complementary since micros-
copy provides the advantage of visualizing the process in
detail in individual cells and flow cytometry allows the
analysis of a large number of events. By microscopy we
measured internalization as the proportion of ligand-QD
present inside individual cells expressing IR-B after dif-
ferent incubation times at 37°C. Complimentary, by flow
cytometry we counted the number of cells exhibiting
internalized ligand-QD655 after stimulation. We calcu-
lated the rate of internalization at the onset as well as
Figure 6 Internalization of IGF-II and insulin through IR-B by flow cytometry. A. HeLa cells expressing IR-B-SYFP labeled in vivo with 50 nM
BAC-Ins and 1 nM QD655 at room temperature were incubated at 37°C for different times. Cells were treated or not with acid for 2 min, before
collection with 0.5 mM EDTA in PBS and analyzed by flow cytometry detecting SYFP and QD655 signals. QD655 histograms were performed with
the population of events which were SYFP positive (transfected cells). Overlays of histograms from cells incubated at 37°C for 90 min and non-
incubated cells for each ligand treatment. In each histogram the geometric mean was calculated and was normalized with respect to the time
defined as zero. Black asterisks show significant differences with the time defined as zero (p≤ 0.05; n = 3 independent experiments). Numeral
symbol indicates significant differences between acid and non acid treatments (p = 0.01; n = 3 independent experiments). B-C. Similar
experiments with BAC-Ins (B) or IGF-II-biot (C). D. In each histogram a marker M1 was determined including approximately 4% of the events at
the time defined as zero. The percentage of events inside region M1 was measured and normalized with respect to the time defined as zero
(Marker/0 min). The results are shown as the mean ± s.e.m (n = 5 independent experiments). Asterisk indicates significant differences between
ligands (p = 0.01).
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results obtained by others using radioactive experiments
[41-43]. Some of these reports are discordant depending
on the cells used or the method of analysis applied.
While for insulin internalization Draznin and colleagues
[41] reported a k = 0.049 min-1 and a half time of 14.5
min, Knuston [44] discussed these results informing a
k = 0.0023 and a half time of 4.9 hours. In our experi-
ments, applying a completely different method, we ob-
tain results closer to those reported by Draznin and
colleagues [41]. In addition, our data confirm that, in
IR-B over-expressing HeLa cells, IGF-II is internalized
faster (half time = 20.3 min) than insulin (half time =
33.6 min). Recently, Morrione et al. [45] showed that in-
sulin and IGF-II regulate endocytic sorting and stability
of the IR-A. They showed that IGF-II induces lower
IR-A activation than insulin. However, this differen-
tial endocytic sorting would protect IR-A from down-
regulation, explaining a more sustained mitogenicity.
This study shows, in an elegant manner, how one same
receptor could be differentially regulated, triggering dif-
ferent signaling responses, after binding two different li-
gands. Although there are important discrepancies in
the field, the overwhelming consensus is that IGF-II has
low affinity for IR-B and high affinity for IR-A compared
with that of insulin. We focused in the study of IR-B
since this receptor is considered to be the one mostly re-
sponsible for the metabolic effect of insulin and we
addressed its dynamics upon binding insulin (a meta-
bolic regulator) and IGF-II (a mitogenic growth factor).
Our interest was to address this open question in vivo
and with new technologies that had not been applied yet
to the insulin/IGF field.
Conclusions
The evidence presented here is consistent with the
model of signal transduction divergence modulated by
the cellular localization of receptor-ligand complexes
[46-55]. Mitogenic ligand-receptor complexes are inter-
nalized more rapidly, thereby triggering signaling from
endosomes; whereas ligand-receptor complexes retained
at the plasma membrane lead to a more metabolic
response. This view is in accordance with a variety of
reports using different experimental approaches. For ex-
ample, insulin analogs exhibiting different receptor dis-
sociation rates indicate that faster dissociating analogs
lead to a more sustained activation of the receptor and a
more persistent activation of Shc [53,56]. On the other
hand, longer signal duration at the level of the recep-
tor leads to a mitogenic response of insulin [56-59]
suggesting that mitogenic signaling is mediated by a
more sustained activation of the IR. Additionally, non-
internalizing IR mutants showed an enhancement of
some biological responses to insulin and attenuation ofothers [52] and pharmacological inhibition of endocyto-
sis demonstrate that the metabolic actions of insulin are
largely independent of insulin receptor endocytosis and
are initiated by activation of the plasma membrane-
localized insulin receptor [40]. We improved the duality
of the studied model using one receptor and two ligands:
a mitogenic one (IGF-II) and a metabolic one (insulin).
Methods
Materials
rhIns was kindly provided by Laboratorios Beta (Buenos
Aires, Argentina). IGF-II-biot was from IBT system
(Reutlingen, Germany) and human recombinant IGF-II
was from Gro Pep (Adelaide, Australia). BAC-Ins was
from Sigma (Munich, Germany). Polyclonal rabbit anti-
ERK2, polyclonal rabbit anti-CD63 (Lamp 1) and poly-
clonal rabbit anti-IR-α-subunit (N20 and H78) were
from Santa Cruz Biotechnology (Paso Robles, CA).
EEA1 marker (rabbit) was from Abcam (Cambridge,
MA). Monoclonal mouse anti-phosphorylated-tyrosine
(PY20) was from BD Transduction Laboratories (Franklin
Lakes, NJ). Monoclonal rabbit anti-phosphorylated-IR-β
subunit (Tyrosine 1361), monoclonal mouse anti-IR-β
subunit and polyclonal rabbit anti-phosphorylated (p42/
44) MAPK were from Cell Signaling Technology (Beverly,
MA). The monoclonal rabbit anti-phosphorylated-IR-β
subunit (Tyrosine 1361) from Cell Signaling (cat # 3023)
only detects transfected levels of IR β subunit and slightly
cross-reacts with activated IGF-I receptor. The strep-
tavidin conjugated QD655 and secondary antibodies con-
jugated with Alexa fluor 555 were from Molecular Probes,
Invitrogen (Eugene, OR). Streptavidin-atto 550 was from
ATTO-TEC Gmbh (Siegen, Germany). Lipofectamine
Reagent 2000, DNase I and Trizol were from Invitrogen
(Carlsbad, CA). High Capacity cDNA Reverse Transcrip-
tion kit was from Applied Biosystem (Foster City, CA).
Cell Titer 96 Aqueous Non-Radioactive Cell Proliferation
Assay (MTS) and Gotaq DNA polymerase were from
Promega (Madison, WI). The plasmid containing the lucif-
erase reporter gene downstream of seven binding sites
for AP-1 (pAP-1-Luc) was provided by Dr. Omar Coso
(IFIBYNE, Argentina).
Plasmids generation
pcDNA3-IR-B: cDNA of IR-B was provided by Dr. Axel
Ullrich (Max Planck Institute for Biophysical Chemistry,
Germany) and amplified by PCR using primers
containing HindIII restriction site (IR-Forward: 5′-
aagcttatggccaccgggggccgg-3′) and NheI and XbaI sites
(IR-Reverse: 5′-tctagagctagcgaaggattggaccgaggcaaggtc-3′).
The product was digested with HindIII and XbaI enzymes
and cloned into the pcDNA3 vector. pcDNA3-IR-B-GFP,
pcDNA3-IR-B-SCFP and pcDNA3-IR-B-SYFP: peGFP-C3
(Clontech), pSCFP-3AC or pSYFP-2F (provided by T. W.
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were digested with NheI and ApaI and cloned into
pcDNA3-IR-B.
Cell culture and transfections
Cell culture reagents (Dulbecco’s modified Eagle’s medium
(DMEM) Glutamax, Optimem, fetal bovine serum (FBS),
trypsin and antibiotics) were from GIBCO (Grand Island,
NE). HeLa cells were maintained in DMEM supplemented
with penicillin, streptomycin and 10% FBS at 37°C in
5% CO2. Human cervical carcinoma HeLa cells (ATCC-
CCL-2) were plated at 1×105 cells/well in 24 well plates
and onto 12 mm glass coverslips (for microscopy experi-
ments) or at 2.5×105 cells/well in 12 wells plates (for
Western blot experiments) one day before transfection in
DMEM supplemented with 10% FBS without antibiotics.
Cells were transfected with Lipofectamine Reagent 2000
for 5 hours using 0.4 μg DNA and 1 μl Lipofectamine per
well for 24 well plates and 0.8 μg DNA and 2 μl
Lipofectamine per well for 12 well plates. After transfec-
tion cells were cultured for further expression in complete
medium.
Western blots
Following stimulation with rhIns, BAC-Ins, IGF-II or
IGF-II-biot cells were lysed in buffer containing 100 mM
Tris–HCl pH 6.8, 4% SDS, 0.2% bromophenol blue, 20%
glycerol, 200 mM β-mercaptoethanol, vortexed for 20
sec and heated 5 min at 100°C. After 10% SDS-PAGE
and transfer, membranes were blocked in 5% w/v non-
fat dried milk in 0.1% Tween-TBS buffer (TTBS) for 1
hour, washed and incubated overnight at 4°C with pri-
mary antibodies diluted in 5% bovine serum albumin
(BSA)/TTBS (anti-IR-β subunit: 1/500, anti-ERK2: 0.2
μg/ml, anti-phosphorylated-p44/42 MAPK: 1/500) or in
2% BSA/TTBS (anti-phosphorylated-Tyrosine: 2 μg/ml).
Membranes were incubated with secondary antibo-
dies for 1 hour and washed with TTBS. The blots were
developed by chemiluminescence with a Bio-Imaging
Analyzer Bas-1800II and Image Gauge 3.12, FUJIFILM.
Luciferase reporter assay
Cells seeded onto 24 well plates (1 × 105 cells/well) the
day before were transfected using 0.3 μg pcDNA3-IR or
pcDNA3 (empty vector, EV) and 0.05 μg pAP1-Luc.
After 24 hours, cells were starved one day, and then
stimulated for 16 hours with 1.6 nM EGF, 100 nM rhIns,
100 nM IGF-II, 1.6 nM EGF + 100nM rhIns or 100 nM
IGF-II + 100 nM rhIns. Luciferase activity was deter-
mined using Luciferase Reactive and Reporter Lysis Buf-
fer from Promega (Madison, WI) and normalization to
the control (non-stimulated cells) was performed (fold
induction). The results were expressed as the mean of atleast three independent experiments ± s.e.m. The p
values were estimated using Student’s T test (2 tails).
Cell proliferation experiments
Cells were transfected with pcDNA3-IR or the EV, 24
hours after transfection they were treated with 1% FBS
overnight before stimulation with 0.1 nM, 1 nM or 10 nM
rhIns or IGF-II for 2 days. Cell proliferation was measured
using a non-radioactive assay (MTS) according to manu-
facturer procedures. The results were normalized to those
obtained for the cells incubated in 1% FBS over all the ex-
periments. The results were expressed as the mean of at
least three independent experiments ± s.e.m. The p values
were estimated using Student’s T test (2 tails).
Labeling in vivo with QDs-IGF-II-biot or BAC-Ins and
internalization
Before the experiment cells expressing IR-B, IR-B-SYFP
or IR-B-GFP were starved overnight, washed with
Tyrode’s buffer (135 mM NaCl, 10 mM KCl, 10 mM
MgCl2, 1mM CaCl2, 10 mM HEPES pH 7.2, 0.1% BSA)
at room temperature or 15°C (as indicated in figure leg-
ends) and incubated with 50 nM BAC-Ins or IGF-II-biot
for 15 min, washed with Tyrode’s and incubated with
0.5, 1.0, 2.0 or 4.0 nM QD655 for 10 min in darkness,
washed and either fixed in 3.7% paraformaldehyde (PFA)
on ice for 20 min or incubated at 37°C in DMEM for
different periods of time before fixation. When acid
treatment was applied, cells were incubated for 5 min
(microscopy) or 2 min (flow cytometry) at room tem-
perature with, 0.5 M NaCl, 0.1 M Na-glycine pH 3.0 and
then fixed in 3.7% PFA for microscopy experiments or
directly analyzed by flow cytometry.
Immunofluorescence
After overnight starvation, transfected cells were stimu-
lated with 100 nM rhIns, IGF-II or IGF-II-biot for 5
min, washed with cold PBS and immediately fixed in
cold methanol for 30 min at −20°C, blocked with PBS/
0.3% Triton X-100/1% BSA for 1 hour at 37°C and incu-
bated with anti-phosphorylated-IR-β subunit (0.3 μg/ml)
overnight at 4°C. The following day the samples were
incubated with a secondary antibody conjugated with
Alexa fluor 555 for 1 hour at 37°C and washed. IR acti-
vation was monitored by confocal microscopy. To study
the expression of IR-B-GFP we followed the same strat-
egy but we did not starve the cells before the assay. We
used anti-IR-α-subunit (N20 and H78) (0.2 μg/ml), the
following day we incubated the cells with a secondary
antibody conjugated with Cy3. For endocytosis immuno-
fluorescence, HeLa cells expressing IR-B were labeled
with BAC-Ins and QD655, induced internalization
and fixed in 3.7% PFA. Immunofluorescences were per-
formed with 4 μg/ml anti-CD63 or 1.5 μg/ml EEA1.
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Confocal laser scanning microscopy was performed
with: (i) an Olympus Fluoview FV 1000 microscope with
a UPLSAPO 60× 1.2 NA water immersion objective.
Excitation and emission filters were as follows: excita-
tion SCFP, 405 nm; emission SCFP, band pass (BP):
430–470 nm; excitation GFP, 488 nm; emission GFP,
BP: 505–605 nm; excitation SYFP, 515 nm; emission
SYFP, BP: 535–565 nm; excitation DAPI, 405 nm; emis-
sion DAPI, BP: 430–470 nm; excitation QD655, 405
nm; emission QD655, BP: 655–755 nm; excitation Alexa
fluor 555, 543 nm; emission Alexa fluor 555, BP: 560–
620 nm; (ii) a Zeiss LSM 510 Meta microscope with a
Plan-Apochromat 63× 1.4 NA oil immersion objective.
Excitation and emission filters were as follows: excita-
tion FITC, 488 nm; emission FITC, 510–563 nm.
We always used the sequential mode for image
acquisition.
In the experiments where imaging was performed
with a Zeiss LSM 510 Meta microscope we used a
C-Apochromat 6× 1.2 NA water immersion objective.
Excitation and emission filters were as follows: excitation
GFP, 488 nm; emission GFP, BP: 500/20 nm; excitation
QD655, 488 nm and 458 nm; emission QD655, LP:
650 nm.
Wide field microscopy was performed with a Zeiss
Axiovert S100 with a 63× 1.25 NA oil immersion object-
ive (Zeiss), a mercury arc lamp excitation and filters
suitable for GFP, Cy3 and DAPI signals. Camera:
Hamamatsu Orca CCD C4742-95.
Image processing
Confocal microscope images were processed with Matlab
(TU Delft, The Netherlands) and Image J (National
Institutes of Health). The background of each channel
(mean of empty region) was subtracted and in some
cases a median filter was applied (radius: 1 pixel) only
for presentation. No filter was applied in quantitative
analyses. The z-stacks (64 frames, 0.16 μm step size)
were processed by deconvolution using Scientific
Volume Imaging Huygens Professional Version 3.6
software, applying a Quick Maximum Likelihood Esti-
mation (QMLE) algorithm.
Internalization analysis
For quantitative internalization experiments, we defined
time “0 min” as the end of labeling-washes, and t = 10,
20 and 150 minutes of incubation at 37°C.
Segmentation (membrane and interior)
Channel backgrounds (median) were subtracted. Seg-
mentation was performed for each cell using the SYFP
signal. After cell segmentation the pre-membrane was
defined as the difference image of the cell and a binaryerosion (iterations: 5–20; alternating connectivity); we
evaluated the results visually. The pre-interior was
defined as the difference between the cell and the pre-
membrane. A QDmask marked red pixels. With this mask
a membrane was defined as the product of the QDmask
and pre-membrane, and interior as the product of the
QDmask and pre-interior obtained previously.
Estimation of the relative amount of internalization
Values in membrane and interior were summed for red
and green channel, and also sizes were measured. To
compute the relative amount of internalized red fluores-
cence we estimated QDtotal as the sum of QDmembrane
and QDinterior and we calculated for each cell the ratio
QDinterior/QDtotal. This “internal calibration” approach
was chosen to remove the influence of the amplifier gain
and the zoom factor for each image acquisition condi-
tion. The expression levels were estimated as the mean
of the SYFP signal (sum of SYFP/cell size) and for the
statistical analysis only cells with similar level of IR-
SYFP expression were considered.
Colocalization analysis
Manders coefficients and PDM graphs were performed
with the Image J plugin Intensity correlation analysis.
The PDM graphs show the contribution of each pixel to
the colocalization coefficient.
Flow cytometry
Flow cytometry was performed with a Becton Dickinson
FACSAriaII. The filters, lasers and dichroic mirrors (DM)
were as follow: (i) SYFP: excitation 488 nm, DM LP: 502
nm, emission BP: 530/30 nm; (ii) QD655: excitation 488
nm, DM LP: 655 nm, emission BP: 660/20 nm. Data ana-
lysis was performed with WinMDI Version 2.9 software.
Positive events for SYFP signal were selected taking into
account basal auto-fluorescence of control cells (non-
transfected cells). QD655 histograms were performed with
the population of events SYFP positive (transfected cells)
and overlays of histograms from cells incubated at 37°C
for 20 or 90 min and non-incubated cells were displayed.
A geometric mean was calculated for each histogram
using the WinMDI. In each histogram a marker M1 was
determined including approximately 4% of the events at
the initial moment (0 min). For each internalization period
the percentage of events inside region M1 was measured
and the normalization was done with respect to the initial
step (0 min) (Marker/0 min).
Graphical fitting
The data for internalization experiments (microscopy
and flow cytometry) were fitted by Origin 8.6 using
sigmoideal logistic curve.
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The results were expressed as the mean ± s.e.m. p values
were estimated using two-tailed Student’s t-tests.
For supplementary methods see Additional file 7.
Additional files
Additional file 1: Figure S1. IR and IGF-IR expression in HeLa cells.
mRNA from HeLa cells was reverse-transcribed and assayed by PCR (RT-
PCR). A. Splicing of exon 11 (36 nt) was assayed using primers that
annealed in the flanking constitutive regions (i.e. exon 10 and exon 12).
PCR products were analyzed by 6% PAGE and percentage of exon
inclusion was quantified by densitometry. B. mRNA levels of IR and IGF-IR
were assayed by RT-PCR with different amounts of cDNA. Quantification
was performed by densitometry in the region where the response was
linear. The results are expressed as the mean ± s.e.m (n = 2 independent
experiments). C. PCR showing IR-B over-expressed in HeLa cells.
Additional file 2: Figure S2. Estimation of transfection efficiency. HeLa
cells were transfected with pcDNA3-IR-B-GFP (A) or pcDNA3-IR-B (B) and
labeled with 50 nM BAC-Ins for 15 min and 1nM QD655 for 10 min. After
labeling cells were imaged by confocal microscopy (Zeiss LSM 510 Meta).
Scale bars: 10 μm. C. Total number of cells was estimated from DIC
images. Transfected cells were estimated from GFP images for IR-B-GFP
and from QD655 images for IR-B. Results are expressed as the mean ± s.e.
m (n = 219 cells for IR-VFP and n = 308 cells for IR from at least 3 images
from 3 independent experiments).
Additional file 3: Figure S3. Expression of IR-B-GFP by
immunofluorescence. HeLa cells expressing IR-B-GFP were fixed in
methanol and then incubated with primary antibodies against two
different regions of the N-terminus of the α-subunit of IR (N20 and H78).
Secondary antibody was conjugated with Cy3. Imaging was carried out
by epifluorescence microscopy (Zeiss Axiovert S100). Scale bars: 5 μm
Additional file 4: Figure S4. Internalization of FITC-Insulin and BAC-
Ins-SA-atto 550. A. HeLa cells over-expressing IR-B-GFP were labeled with
50 nM BAC-Ins for 15 min and then with 1 nM SA-atto 550 for 10 min at
RT. Cells were directly fixed in PFA (upper panel) or incubated at 37°C for
60 min before fixation (middle panel). Lower panel shows the control
experiment where the cells were treated similarly but without incubation
with BAC-Ins. Imaging was performed by confocal microscopy (Olympus
Fluoview FV1000). Scale bars: 10 μm. B. HeLa cells transfected with
pcDNA3-IR-B were labeled with 50 nM FITC-insulin for 15 min and then
directly fixed in methanol (upper panel) or incubated at 37°C for 75 min
before fixation (middle panel). Lower panel shows similar experiment but
in non transfected HeLa cells. Imaging was performed by confocal
microscopy (Zeiss LSM 510 Meta). Scale bars: 10 μm.
Additional file 5: Movie S1. Visualization of IGF-II-biot-QD655 bound to
IR-B-GFP and endocytosed. HeLa cells expressing IR-B-GFP were labeled
in vivo with 50 nM IGF-II-biot and 2 nM QD655, incubated at 37°C for 1
hour, treated for 5 min with 0.1 mM Na-glycine pH 3.0, NaCl 0.5 M and
fixed in 3.7% PFA. Images were taken with a confocal microscope by
acquisition of 64 z-slices with 16 μm step size. Deconvolution was
performed with Huygens Scientific Volume Imaging Huygens Professional
Version 3.6, applying the Quick maximum likelihood estimation algorithm.
The movie shows tridimensional reconstruction using the surface
renderer process observed from different angles.
Additional file 6: Figure S5. Specificity of the binding of BAC-Ins and
IGF-II-biot to the IR-B by flow cytometry. HeLa cells over-expressing IR-B
(A-C) or IR-B-SYFP (D and E) were labeled in vivo with 50 nM BAC-Ins and
1 nM QD655 (C and E) or only with 1 nM QD655 (B and D). Cells were
collected with 0.5 mM EDTA in PBS and were analyzed by flow cytometry
detecting SYFP and QD655 signals. The images inside the graphs
correspond to similar experiments but analyzed by confocal microscopy
(QD655 are shown in red and SYFP in green). F. Quantification of the
proportion of events in the region II (see panel A) with high signal of
SYFP (transfected cells) and high signal of QD655 (insulin or IGFII
binding). We normalized this value to the proportion obtained for the
cells only incubated with QD655 without biotinylated ligand. G. HeLacells expressing IR-B-SYFP were labeled in vivo with 50 nM IGF-II-biot and
1 nM QD655 at room temperature and were treated (or not) with acid
(0.1 M Na-glycine pH 3, 0.5 M NaCl) for 2 min. After washing with PBS,
cells were collected with 0.5 mM EDTA in PBS and analyzed by flow
cytometry detecting SYFP and QD655 signals. The bar graph shows the
quantification of the ratio between the events inside region II and the
events inside region (II + IV). Asterisks indicate significant differences
(p ≤ 0.001; n = 3 independent experiments).
Additional file 7. Supplementary methods.
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